Observational studyScientific reports2025

JAVEMACS-D: claims database analysis of avelumab maintenance therapy for advanced urothelial carcinoma in Japan.

Takashi Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.